phorbolol myristate acetate has been researched along with tamoxifen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahluwalia, J | 1 |
| Chen, L; Jin, X; Li, H; Mao, J; Wang, L; Xu, B; Yuan, J; Zhang, H; Zhu, J | 1 |
2 other study(ies) available for phorbolol myristate acetate and tamoxifen
| Article | Year |
|---|---|
Tamoxifen does not inhibit the swell activated chloride channel in human neutrophils during the respiratory burst.
Topics: Cells, Cultured; Chloride Channels; Colforsin; Humans; N-Formylmethionine Leucyl-Phenylalanine; NADPH Oxidases; Neutrophils; Phloretin; Respiratory Burst; Superoxides; Tamoxifen; Tetradecanoylphorbol Acetate; Trialkyltin Compounds | 2008 |
Tamoxifen inhibits migration of estrogen receptor-negative hepatocellular carcinoma cells by blocking the swelling-activated chloride current.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Size; Chloride Channels; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Neoplasm Metastasis; Receptors, Estrogen; RNA, Small Interfering; Tamoxifen; Tetradecanoylphorbol Acetate | 2013 |